Teleflex Incorporated (TFX) Shares Sold by Nicholas Company Inc.
Nicholas Company Inc. reduced its position in Teleflex Incorporated (NYSE:TFX) by 10.0% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 83,760 shares of the medical technology company’s stock after selling 9,270 shares during the period. Nicholas Company Inc. owned approximately 0.19% of Teleflex worth $17,401,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in TFX. Marshall Wace North America L.P. lifted its stake in shares of Teleflex by 137.4% in the 2nd quarter. Marshall Wace North America L.P. now owns 518,462 shares of the medical technology company’s stock valued at $107,840,000 after purchasing an additional 300,069 shares in the last quarter. Principal Financial Group Inc. lifted its stake in shares of Teleflex by 93.5% in the 2nd quarter. Principal Financial Group Inc. now owns 610,398 shares of the medical technology company’s stock valued at $126,816,000 after purchasing an additional 294,935 shares in the last quarter. FMR LLC lifted its stake in shares of Teleflex by 46.5% in the 1st quarter. FMR LLC now owns 811,764 shares of the medical technology company’s stock valued at $157,263,000 after purchasing an additional 257,649 shares in the last quarter. MARSHALL WACE ASIA Ltd acquired a new position in shares of Teleflex in the 1st quarter valued at about $42,368,000. Finally, Vanguard Group Inc. lifted its stake in shares of Teleflex by 5.2% in the 1st quarter. Vanguard Group Inc. now owns 3,781,475 shares of the medical technology company’s stock valued at $732,584,000 after purchasing an additional 186,845 shares in the last quarter. 90.50% of the stock is currently owned by institutional investors and hedge funds.
COPYRIGHT VIOLATION NOTICE: This report was originally published by Daily Political and is the sole property of of Daily Political. If you are reading this report on another website, it was illegally stolen and reposted in violation of U.S. & international trademark and copyright legislation. The legal version of this report can be read at https://www.dailypolitical.com/2017/09/15/teleflex-incorporated-tfx-shares-sold-by-nicholas-company-inc.html.
Shares of Teleflex Incorporated (NYSE TFX) traded up 0.15% during midday trading on Friday, hitting $234.64. The company had a trading volume of 92,284 shares. The company’s 50 day moving average is $214.08 and its 200 day moving average is $203.96. Teleflex Incorporated has a one year low of $136.53 and a one year high of $236.02. The firm has a market cap of $10.57 billion, a price-to-earnings ratio of 44.87 and a beta of 1.05.
Teleflex (NYSE:TFX) last issued its earnings results on Thursday, August 3rd. The medical technology company reported $2.04 EPS for the quarter, beating analysts’ consensus estimates of $1.91 by $0.13. Teleflex had a return on equity of 16.12% and a net margin of 12.36%. The firm had revenue of $528.60 million for the quarter, compared to the consensus estimate of $518.98 million. During the same quarter in the previous year, the company posted $1.89 earnings per share. The business’s quarterly revenue was up 11.6% compared to the same quarter last year. Equities analysts forecast that Teleflex Incorporated will post $8.28 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Friday, September 15th. Stockholders of record on Tuesday, August 15th will be paid a dividend of $0.34 per share. The ex-dividend date is Friday, August 11th. This represents a $1.36 annualized dividend and a dividend yield of 0.58%. Teleflex’s dividend payout ratio (DPR) is presently 26.00%.
Several equities analysts have recently weighed in on the company. Jefferies Group LLC lifted their price objective on Teleflex from $253.00 to $270.00 and gave the company a “buy” rating in a research note on Friday, September 8th. KeyCorp reaffirmed a “hold” rating on shares of Teleflex in a research note on Wednesday, September 6th. BidaskClub lowered Teleflex from a “hold” rating to a “sell” rating in a research note on Tuesday, August 8th. Zacks Investment Research lowered Teleflex from a “buy” rating to a “hold” rating in a research note on Saturday, September 9th. Finally, Barclays PLC reaffirmed an “overweight” rating and issued a $253.00 price objective (up from $230.00) on shares of Teleflex in a research note on Tuesday. One research analyst has rated the stock with a sell rating, one has given a hold rating and eight have assigned a buy rating to the company. The company currently has a consensus rating of “Buy” and a consensus target price of $257.00.
In other news, Director Stephen K. M.D. Klasko sold 200 shares of the company’s stock in a transaction dated Monday, July 3rd. The stock was sold at an average price of $208.10, for a total transaction of $41,620.00. Following the completion of the sale, the director now owns 8,080 shares in the company, valued at approximately $1,681,448. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Gretchen R. Haggerty purchased 1,000 shares of the firm’s stock in a transaction dated Wednesday, June 21st. The shares were bought at an average price of $203.82 per share, with a total value of $203,820.00. Following the purchase, the director now owns 1,760 shares in the company, valued at approximately $358,723.20. The disclosure for this purchase can be found here. In the last quarter, insiders have sold 600 shares of company stock valued at $125,652. 2.39% of the stock is currently owned by corporate insiders.
Teleflex Company Profile
Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company operates through six segments: Vascular North America; Anesthesia North America; Surgical North America; Europe, the Middle East and Africa (EMEA); Asia, and Original Equipment Manufacturer (OEM).
Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFX).
Receive News & Ratings for Teleflex Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.